Rejane de Paula Meneses

Learn More
The efficacy and safety of valsartan were studied in 90 children (mean age: 3.2 years; 60% male; 30% black) with systolic blood pressure (SBP) > or =95th percentile. Nineteen percent received valsartan in addition to previous antihypertensive therapy. Subjects were randomly assigned to low-, medium-, or high-dose valsartan for 2 weeks (phase 1) and then(More)
The present study aimed to evaluate whether or not quantitative changes occur in the salivary flow of patients with chronic renal insufficiency (CRI) who have been submitted to Hemodialysis. Twenty-nine chronic renal patients, between 4 and 25 years of age, submitted to Hemodialysis at Hospital Pequeno Príncipe in Curitiba, Paraná, Brazil participated in(More)
  • 1